D-1131-2015 Class II Terminated
FDA drug recall D-1131-2015 was initiated by Baxter Healthcare Corp on Jun 3, 2015 and is designated Class II. Reason for recall: Subpotent Drug; out of specification results for heparin raw material The recall status is terminated (terminated Mar 14, 2017). Affected quantity: 145,350 containers.
Recall Details
- Product Type
- Drugs
- Report Date
- Jun 17, 2015
- Initiation Date
- Jun 3, 2015
- Termination Date
- Mar 14, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 145,350 containers
Product Description
Heparin Sodium and 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL --- NDC 0338-0431-03
Reason for Recall
Subpotent Drug; out of specification results for heparin raw material
Distribution Pattern
Nationwide
Code Information
Product Code: 280953 Lots: N002998 and N003004 exp 12/31/15; and lot N003038 exp. 01/31/2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1131-2015
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026